Dietary supplementation: Effects on visual performance and occurrence of AMD and cataracts

Current Medical Research and Opinion

Volumn 26, Issue 8, 2010, Pages 2011-2023

  Barker II, Felix M ^a  

^a SALUS UNIVERSITY   (United States)

Author keywords

AMD; Cataract; Diet; Lutein; Vision; Zeaxanthin

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CUPRIC OXIDE; NICOTINIC ACID; RIBOFLAVIN; XANTHOPHYLL; ZEAXANTHIN; ZINC OXIDE;

CATARACT; CLINICAL ASSESSMENT; CONTRAST SENSITIVITY; DIET SUPPLEMENTATION; DISEASE COURSE; HUMAN; MEDLINE; OPTICAL DENSITY; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; VISION; VISUAL ACUITY;

CATARACT; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; HUMANS; MACULAR DEGENERATION; RISK FACTORS; VISUAL ACUITY;

EID: 77954697579     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.494549     Document Type: Review

References (92)

1. Whitehead AJ, Mares JA, Danis RP. Macular pigment: a review of current knowledge. Arch Ophthalmol 2006;124:1038-45
2. Kolb H. The architecture of functional neural circuits in the vertebrate retina. The Proctor Lecture. Invest Ophthalmol Vis Sci 1994;35:2385-404
3. Stringham JM, Hammond Jr BR The glare hypothesis of macular pigment function. Optom Vis Sci 2007;84:859-64
4. Wooten BR, Hammond BR. Macular pigment: influences on visual acuity and visibility. Prog Retin Eye Res 2002;21:225-40
5. Kim HJ, Kim YY, Kim SY. Effect of zinc on the visual sensitivity of the bullfrog's eye. Korean J Ophthalmol 2000;14:53-9
6. Hammond Jr BR, Wooten BR, Curran-Celentano J. Carotenoids in the retina and lens: possible acute and chronic effects on human visual performance. Arch Biochem Biophys 2001;385:41-6
7. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 2003;23:171-201
8. Ahmed SS, Lott MN, Marcus DM. The macular xanthophylls. Surv Ophthalmol 2005;50:183-93
9. Bartlett H, Eperjesi F. An ideal ocular nutritional supplement? Ophthalmic Physiol Opt 2004;24:339-49
10. Carpentier S, Knaus M, Suh M. Associations between lutein, zeaxanthin, and age-related macular degeneration: an overview. Crit Rev Food Sci Nutr 2009;49:313-26
11. Johnson EJ. Age-related macular degeneration and antioxidant vitamins: recent findings. Curr Opin Clin Nutr Metab Care 2010;13:28-33
12. Fernandez MM, Afshari NA. Nutrition and the prevention of cataracts. Curr Opin Ophthalmol 2008;19:66-70
13. Meyer CH, Sekundo W. Nutritional supplementation to prevent cataract formation. Dev Ophthalmol 2005;38:103-19
14. Seddon JM. Multivitamin-multimineral supplements and eye disease: age-related macular degeneration and cataract. Am J Clin Nutr 2007;85:304-7S
15. Chiu CJ, Taylor A. Nutritional antioxidants and age-related cataract and maculopathy. Exp Eye Res 2007;84:229-45
16. Jewell VC, Northrop-Clewes CA, Tubman R, et al. Nutritional factors and visual function in premature infants. Proc Nutr Soc 2001;60:171-8
17. Curran-Celentano J, Hammond Jr BR, Ciulla TA, et al. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr 2001;74:796-802
18. Beatty S, Nolan J, Kavanagh H, et al. Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Arch Biochem Biophys 2004;430:70-6
19. Nolan JM, Stack J, O'Connell E, et al. The relationships between macular pigment optical density and its constituent carotenoids in diet and serum. Invest Ophthalmol Vis Sci 2007;48:571-82
20. Hammond Jr BR, Johnson EJ, Russell RM, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 1997;38:1795-801
21. Bone RA, Landrum JT, Cao Y, et al. Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin. Nutr Metab (Lond) 2007;4:12
22. Trieschmann M, Beatty S, Nolan JM, et al. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res 2007;84:718-28
23. Landrum JT, Bone RA, Joa H, et al. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res 1997; 65:57-62
24. Bone RA, Landrum JT, Guerra LH, et al. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr 2003;133:992-8
25. Mares JA, LaRowe TL, Snodderly DM, et al. Predictors of optical density of lutein and zeaxanthin in retinas of older women in the carotenoids in age-related eye disease study, an ancillary study of the women's health initiative. Am J Clin Nutr 2006;84:1107-22
26. Johnson EJ, Chung HY, Caldarella SM, et al. The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation. Am J Clin Nutr 2008;87:1521-9
27. Stringham JM, Hammond BR. Macular pigment and visual performance under glare conditions. Optom Vis Sci 2008;85:82-8
28. Wenzel AJ, Fuld K, Stringham JM, et al. Macular pigment optical density and photophobia light threshold. Vision Res 2006;46:4615-22
29. Ma L, Lin XM, Zou ZY, et al. A 12-week lutein supplementation improves visual function in Chinese people with long-term computer display light exposure. Br J Nutr 2009;102:186-90
30. Bartlett HE, Eperjesi F. A randomised controlled trial investigating the effect of lutein and antioxidant dietary supplementation on visual function in healthy eyes. Clin Nutr 2008;27:218-27
31. Kniestedt C, Stamper RL. Visual acuity and its measurement. Ophthalmol Clin North Am 2003;16:155-70
32. Haegerstrom-Portnoy G, Brabyn J, Schneck ME, et al. The SKILL Card. An acuity test of reduced luminance and contrast. Smith-Kettlewell Institute Low Luminance. Invest Ophthalmol Vis Sci 1997;38:207-18
33. Kvansakul J, Rodriguez-Carmona M, Edgar DF, et al. Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance. Ophthalmic Physiol Opt 2006;26:362-71
34. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 2001;385:28-40
35. Cook HL, Patel PJ, Tufail A. Age-related macular degeneration: diagnosis and management. Br Med Bull 2008;85:127-49
36. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med 2008;358:2606-17
37. Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 2006;58:353-63
38. Klein R, Peto T, Bird A, et al. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004;137:486-95
39. Arden GB. Age-related macular degeneration. J Br Menopause Soc 2006;12:64-70
40. Peters S, Lamah T, Kokkinou D, et al. Melanin protects choroidal blood vessels against light toxicity. Z Naturforsch [C] 2006;61:427-33
41. Berendschot TT, van Norren D. On the age dependency of the macular pigment optical density. Exp Eye Res 2005;81:602-9
42. Bernstein PS, Zhao DY, Wintch SW, et al. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 2002;109:1780-7
43. Obana A, Hiramitsu T, Gohto Y, et al. Macular carotenoid levels of normal subjects and age-related maculopathy patients in a Japanese population. Ophthalmology 2008;115:147-57
44. Age-Related Eye Disease Study Research Group, SanGiovanni JP, Chew EY, et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol 2007;125:1225-32
45. Tan JS, Wang JJ, Flood V, et al. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 2008;115:334-41
46. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Dietary intake of antiox-idants and risk of age-related macular degeneration. JAMA 2005;294: 3101-7
47. Moeller SM, Parekh N, Tinker L, et al. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol 2006;124:1151-62
48. Chong EW, Robman LD, Simpson JA, et al. Fat consumption and its association with age-related macular degeneration. Arch Ophthalmol 2009;127:674-80
49. Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol 2006;124:995-1001
50. SanGiovanni JP, Chew EY, Clemons TE, et al. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol 2007;125:671-9
51. SanGiovanni JP, Chew EY, Agrón E, et al. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol 2008;126: 1274-9
52. Taylor HR, Tikellis G, Robman LD, et al. Vitamin E supplementation and macular degeneration: randomised controlled trial. BMJ 2002;325:11
53. Teikari JM, Laatikainen L, Virtamo J, et al. Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol Scand 1998;76:224-9
54. Christen WG, Manson JE, Glynn RJ, et al. Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians. Arch Ophthalmol 2007;125:333-9
55. Dorey CK, Granata L, Nichols CR, et al. Dietary modulation of lens zeaxanthin in quail. Exp Eye Res 2005;81:464-77
56. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-36
57. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 2004;75:216-30
58. Parisi V, Tedeschi M, Gallinaro G, et al. Carotenoids and antioxidants in age-related maculopathy Italian study: multifocal electroretinogram modifications after 1 year. Ophthalmology 2008;115:324-33
59. Cangemi FE. TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD. BMC Ophthalmol 2007;7:3
60. Asbell PA, Dualan I, Mindel J, et al. Age-related cataract. Lancet 2005;365:599-609
61. WHO. Global initiative for the elimination of avoidable blindness. Fact sheet number 213. Geneva: WHO, 2000. Available at: http://www.who.int/media- centre/factsheets/fs213/en/Last accessed 21 October 2009
62. WHO. Blindness and visual disability: major causes worldwide. Fact sheet number 143. Geneva: WHO, 1997. Available at: http://www.who.int/mediacentre/ factsheets/fs413/en/Last accessed 21 October 2009
63. Gohdes DM, Balamurugan A, Larsen BA, et al. Age-related eye diseases: an emerging challenge for public health professionals. Prev Chronic Dis 2005;2:A17
64. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122:477-85
65. Congdon N, Vingerling JR, Klein BE, et al. Prevalence of cataract and pseu-dophakia/aphakia among adults in the United States. Arch Ophthalmol 2004;122:487-94
66. Sperduto RD, Clemons TE, Lindblad AS, et al. Cataract classification using serial examinations in the age-related eye disease study: age-related eye disease study report no. 24. Am J Ophthalmol 2008;145:504-8
67. Robman L, Taylor H. External factors in the development of cataract. Eye 2005;19:1074-82
68. Truscott RJ. Age-related nuclear cataract-oxidation is the key. Exp Eye Res 2005;80:709-25
69. Kilic F, Bhardwaj R, Caulfeild J, et al. Modelling cortical cataractogenesis 22: is in vitro reduction of damage in model diabetic rat cataract by taurine due to its antioxidant activity? Exp Eye Res 1999;69:291-300
70. Pau H. Cortical and subcapsular cataracts: significance of physical forces. Ophthalmologica 2006;220:1-5
71. Bernstein PS, Khachik F, Carvalho LS, et al. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res 2001;72:215-23
72. Yeum KJ, Shang FM, Schalch WM, et al. Fat-soluble nutrient concentrations in different layers of human cataractous lens. Curr Eye Res 1999;19:502-5
73. Chitchumroonchokchai C, Bomser JA, Glamm JE, et al. Xanthophylls and alpha-tocopherol decrease UVB-induced lipid peroxidation and stress signaling in human lens epithelial cells. J Nutr 2004;134:3225-32
74. Trevithick-Sutton CC, Foote CS, Collins M, et al. The retinal carotenoids zeaxanthin and lutein scavenge superoxide and hydroxyl radicals: a chemi-luminescence and ESR study. Mol Vis 2006;12:1127-35
75. Bhosale P, Zhao da Y, Bernstein PS. HPLC measurement of ocular carotenoid levels in human donor eyes in the lutein supplementation era. Invest Ophthalmol Vis Sci 2007;48:543-9
76. Dherani M, Murthy GV, Gupta SK, et al. Blood levels of vitamin C, carotenoids and retinol are inversely associated with cataract in a North Indian population. Invest Ophthalmol Vis Sci 2008;49:3328-35
77. Vu HT, Robman L, Hodge A, et al. Lutein and zeaxanthin and the risk of cataract: the Melbourne visual impairment project. Invest Ophthalmol Vis Sci 2006;47:3783-6
78. Tan AG, Mitchell P, Flood VM, et al. Antioxidant nutrient intake and the long-term incidence of age-related cataract: the Blue Mountains Eye Study. Am J Clin Nutr 2008;87:1899-905
79. Moeller SM, Voland R, Tinker L, et al. Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an Ancillary Study of the Women's Health Initiative. Arch Ophthalmol 2008;126:354-64
80. Mares-Perlman JA, Lyle BJ, Klein R, et al. Vitamin supplement use and incident cataracts in a population-based study. Arch Ophthalmol 2000;118:1556-63
81. Valero MP, Fletcher AE, De Stavola BL, et al. Vitamin C is associated with reduced risk of cataract in a Mediterranean population. J Nutr 2002;132:1299-306
82. Gale CR, Hall NF, Phillips DI, et al. Plasma antioxidant vitamins and caroten-oids and age-related cataract. Ophthalmology 2001;108:1992-8
83. Vitale S, West S, Hallfrisch J, et al. Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology 1993;4:195-203
84. Jacques PF, Chylack Jr LT, Hankinson SE, et al. Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol 2001; 119:1009-19
85. Townend BS, Townend ME, Flood V, et al. Dietary macronutrient intake and five-year incident cataract: the blue mountains eye study. Am J Ophthalmol 2007;143:932-9
86. Lu M, Cho E, Taylor A, et al. Prospective study of dietary fat and risk of cataract extraction among US women. Am J Epidemiol 2005; 161:948-59
87. Milton RC, Sperduto RD, Clemons TE, et al. Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study: a propensity score approach. AREDS report No. 21. Ophthalmology 2006; 113:1264-70
88. Maraini G, Sperduto RD, Ferris F, et al. A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities. Clinical trial of nutritional supplements and age-related cataract report no. 3. Ophthalmology 2008;115:599-607
89. Taylor A, Jacques PF, Chylack Jr LT, et al. Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities. Am J Clin Nutr 2002;75:540-9
90. Sperduto RD, Hu TS, Milton RC, et al. The Linxian cataract studies. Two nutrition intervention trials. Arch Ophthalmol 1993;111:1246-53
91. Tan J, Wang JJ, Flood V, et al. Carbohydrate nutrition, glycemic index, and the 10-y incidence of cataract. Am J Clin Nutr 2007;86:1502-8
92. Kelly SP, Thornton J, Edwards R, et al. Smoking and cataract: review of causal association. J Cataract Refract Surg 2005;31:2395-404